143 related articles for article (PubMed ID: 6438999)
21. Sural nerve immune deposits in polyneuropathy as a remote effect of malignancy.
Ongerboer de Visser BW; Feltkamp-Vroom TM; Feltkamp CA
Ann Neurol; 1983 Sep; 14(3):261-6. PubMed ID: 6357048
[TBL] [Abstract][Full Text] [Related]
22. Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis.
Madrid FF; Maroun MC; Olivero OA; Long M; Stark A; Grossman LI; Binder W; Dong J; Burke M; Nathanson SD; Zarbo R; Chitale D; Zeballos-Chávez R; Peebles C
BMC Cancer; 2015 May; 15():407. PubMed ID: 25975273
[TBL] [Abstract][Full Text] [Related]
23. Reactivity of a monoclonal antibody with tissues and tumors from the human breast. Immunohistochemical localization of a new antigen and clinicopathologic correlations.
Mariani-Costantini R; Barbanti P; Colnaghi MI; Ménard S; Clemente C; Rilke F
Am J Pathol; 1984 Apr; 115(1):47-56. PubMed ID: 6711680
[TBL] [Abstract][Full Text] [Related]
24. [Possibility of using the indirect fluorescent antibody technic to analyze immunoglobulins in certain neurogenetic diseases].
Gannushkina IV; Zhirnova IG; Alieva LM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(9):1297-1301. PubMed ID: 6449124
[TBL] [Abstract][Full Text] [Related]
25. [Autoantibodies in malignant tumors].
Storch H; Uhlig S; Ludwig R
Z Gesamte Inn Med; 1980 Jun; 35(11):471-4. PubMed ID: 7001779
[TBL] [Abstract][Full Text] [Related]
26. Antibody studies of sera from patients with breast cancer.
Estes NC; Morse PA; Humphrey LJ
Surg Forum; 1974; 25(0):121-3. PubMed ID: 4612763
[No Abstract] [Full Text] [Related]
27. In vitro synthesis of immunoglobulins and other proteins by dysplastic and neoplastic human mammary tissues.
Hurlimann J; Lichaa M; Ozzello L
Cancer Res; 1976 Apr; 36(4):1284-92. PubMed ID: 56996
[TBL] [Abstract][Full Text] [Related]
28. The significance of p53 autoantibodies in the serum of patients with breast cancer.
Willsher PC; Pinder SE; Robertson L; Nicholson RI; Ellis IO; Bell JA; Blamey RW; Green JA; Robertson JF
Anticancer Res; 1996; 16(2):927-30. PubMed ID: 8687153
[TBL] [Abstract][Full Text] [Related]
29. Immunologic studies of human breast cancer. I. Serum reactivity against a lymphoid cell line (Belev) derived from a breast cancer patient as detected by complement-fixation test.
Chan SP; Maca RD; Levine PH; Ting RC
J Natl Cancer Inst; 1971 Sep; 47(3):511-7. PubMed ID: 5157574
[No Abstract] [Full Text] [Related]
30. Deposition of complement C1q in primary localized cutaneous amyloidosis.
Danno K; Imamura S
Br J Dermatol; 1982 Feb; 106(2):129-33. PubMed ID: 7037040
[TBL] [Abstract][Full Text] [Related]
31. [Non-specific changes in the complement system in neoplastic processes].
Tiagotin IuV; Rybakova LP; Golota GZ; Ishchenko AM
Vopr Onkol; 2002; 48(2):206-10. PubMed ID: 12227070
[TBL] [Abstract][Full Text] [Related]
32. Studies of serum from patients with breast cancer.
Mahoney JC; Boehm OR; Boehm BJ; Humphrey LJ
Surg Forum; 1972; 23(0):87-8. PubMed ID: 4210083
[No Abstract] [Full Text] [Related]
33. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells.
Hakulinen J; Meri S
Lab Invest; 1994 Dec; 71(6):820-7. PubMed ID: 7528832
[TBL] [Abstract][Full Text] [Related]
34. [Application of the immunofluorescente (fluorescent antibody technique) in clinical immunology.--II. Application and significance (author's transl)].
Arnold W
Immun Infekt; 1976 Jun; 4(3):126-40. PubMed ID: 134971
[TBL] [Abstract][Full Text] [Related]
35. Detection of a breast tissue-associated antigen by antiserum to Raji cell-bound circulating immune complexes of human breast cancer.
Koestler TP; Papsidero LD; Nemoto T; Chu TM
Cancer Res; 1981 Jul; 41(7):2900-7. PubMed ID: 7018673
[TBL] [Abstract][Full Text] [Related]
36. Novel human autoantibodies to phosphoepitopes on mitotic chromosomal autoantigens (MCAs).
Gitlits VM; Macaulay SL; Toh BH; Sentry JW
J Investig Med; 2000 May; 48(3):172-82. PubMed ID: 10822897
[TBL] [Abstract][Full Text] [Related]
37. CD95 ligand expression in dedifferentiated breast cancer.
Müschen M; Moers C; Warskulat U; Niederacher D; Betz B; Even J; Lim A; Josien R; Beckmann MW; Häussinger D
J Pathol; 1999 Nov; 189(3):378-86. PubMed ID: 10547600
[TBL] [Abstract][Full Text] [Related]
38. [Immunohistological studies for demonstration of carcinoembryonic antigen in benign breast lesions].
Wittekind C; von Kleist S; Sandritter W
Onkologie; 1982 Aug; 5 Suppl():25-7. PubMed ID: 6752789
[TBL] [Abstract][Full Text] [Related]
39. Factors involved in the plasminogen activation system in human breast tumours.
Damjanovich L; Turzó C; Adány R
Thromb Haemost; 1994 Jun; 71(6):684-91. PubMed ID: 7974332
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibody 5C3 raised against formalin fixed paraffin-embedded invasive breast tumour tissue: characterisation of its reactive antigen via immunoprecipitation and internal sequencing.
Larkin A; Moran E; Kennedy SM; Clynes M
J Immunol Methods; 2005 Aug; 303(1-2):53-65. PubMed ID: 16038928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
